Sort
34,240 grants matching “atherosclerosis”
Role of CHF1 in Occlusive Vascular Disease
$368,416Brigham And Women'S Hospital · R01 · FY2005 · HL
Macrophage-specific targeting of LXRs in CVD and NASH
$368,384Christopher K Glass · University Of California, San Diego · P01 · FY2021 · HL
Pivotal Role of Oxidation-specific Epitopes in CVD and NASH.
$368,382Joseph L Witztum · University Of California, San Diego · P01 · FY2021 · HL
Macrophage-specific targeting of LXRs in CVD and NASH
$368,371Christopher K Glass · University Of California, San Diego · P01 · FY2023 · HL
Pivotal Role of Oxidation-specific Epitopes in CVD and NASH.
$368,369Joseph L Witztum · University Of California, San Diego · P01 · FY2023 · HL
HEMODYNAMICS AND MOLECULAR GENETIC RISK FACTORS IN ATHEROSCLEROSIS
$368,363Brigham And Women'S Hospital · P50 · FY2000 · HL
MOLECULAR DETERMINANTS OF THE STABILITY OF ATHEROMA
$368,363Brigham And Women'S Hospital · P50 · FY2000 · HL
NUCLEAR FACTOR KAPPA BETA AND THE INITIATION OF THE ATHEROSCLEROTIC LESION
$368,363Brigham And Women'S Hospital · P50 · FY2000 · HL
DETECTION AND MODULATION OF THE VULNERABLE ATHEROSCLEROTIC PLAQUE
$368,363Brigham And Women'S Hospital · P50 · FY2000 · HL
CELLULAR IMMUNE MECHANISM IN ATHEROGENESIS
$368,363Brigham And Women'S Hospital · P50 · FY2000 · HL
Bioengineering approaches to map mechanotransduction in the living cell
$368,354Ning Wang · University Of Illinois At Urbana-Champaign · R01 · FY2011 · GM
Novel mechanism of smooth muscle phenotypic modulation and vascular remodeling
$368,349Shiyou Chen · University Of Georgia · R01 · FY2015 · HL
Physical Activity and Preservation of Cognitive Function
$368,339Priya Palta · Columbia University Health Sciences · R00 · FY2021 · AG
Gut Microbiota and Atherosclerosis in ESRD
$368,337Dominic S Raj · George Washington University · U01 · FY2017 · DK
Insulin Resistance and Adenomas of the Colorectum
$368,276Wake Forest University Health Sciences · R01 · FY2003 · CA
Macrophage inflammasome activation and the mechanism of lipolysis resistance in aged adipose
$368,265Christina Camell · University Of Minnesota · R00 · FY2020 · AG
Mechanisms of Human Cytomegalovirus Latency in Primary Human Hematopoietic Cells
$368,252Felicia D Goodrum · University Of Arizona · R01 · FY2010 · AI
Local complement activation in inflammation & disease: therapeutic implications
$368,252Georgios Hajishengallis · University Of Pennsylvania · P01 · FY2016 · AI
Local complement activation in inflammation & disease: therapeutic implications
$368,251Georgios Hajishengallis · University Of Pennsylvania · P01 · FY2018 · AI
Local complement activation in inflammation & disease: therapeutic implications
$368,251Georgios Hajishengallis · University Of Pennsylvania · P01 · FY2017 · AI
HIV protease inhibitors, marcophage function/estrogen
$368,250University Of Kentucky · R01 · FY2004 · HL
Group V sPLA2 in Atherosclerosis
$368,250University Of Kentucky · R01 · FY2005 · HL
HIV protease inhibitors, marcophage function/estrogen
$368,250University Of Kentucky · R01 · FY2003 · HL
HIV protease inhibitors, marcophage function/estrogen
$368,250University Of Kentucky · R01 · FY2005 · HL
Selective Insulin Resistance- Diabetic Cardiovascular Diseases
$368,238George L King · Joslin Diabetes Center · R01 · FY2017 · DK